BioRock Ventures

BioRock Ventures is a seed-stage venture capital fund based in Palo Alto, California, focusing on investments in novel medicines and biopharmaceutical startups. The firm specializes in early-stage funding, primarily participating in seed and Series A rounds for companies developing innovative treatments for serious medical conditions.

One of BioRock Ventures' notable portfolio companies is Primmune Therapeutics, which has raised a total of $34.4 million. The firm's investment strategy centers on identifying and supporting promising life sciences startups with the potential to create groundbreaking medical solutions. BioRock Ventures aims to contribute to the development of tomorrow's medicines by providing early-stage capital and support to innovative biopharmaceutical companies.